Case report · 10 Aug 2026
Conference abstractPublished 16 Jul 2018
LHRH-modified curcumin-loaded polymeric micellar formulation effect on colorectal cancer cell lines in vitro
The University of Sydney, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The overexpression of Luteinizing Hormone Releasing Hormone Receptors (LHRH-R) on Colorectal Cancer (CRC) gives the opportunity to use LHRH peptide as a potential targeting agent in CRC. Curcumin is known for its in vitro chemotherapeutics, chemo-preventive effect against variety of types of cancer including CRC. However; its therapeutic potential is compromised due to its limited water solubility and low metabolic stability. Curcumin-loaded polymeric micellar Nanoparticles (Cur-NP) were developed aiming to enhance the water solubility and therapeutic potential of curcumin. To actively target the nanoparticle to CRC tissue, the surface of the nanoparticles was functionalized using LHRH peptide analogue. The nanoparticlesÃ?¢Ã?Â?Ã?Â? cytotoxicity on Caco-2 and HCT-116 colon cancer cell lines was examined using MTT and live cell imaging by IncuCyte ZOOM. The natural fluorescence of curcumin allowed the detection of the cellular uptake of the formulation using Confocal Laser Scanning Microscopy (CLSM) and IncuCyteÃ?Â?Ã?® ZOOM. Furthermore, using a new approach the uptake of LHRH-modified and unmodified nanoparticles were quantified using IncuCyteÃ?Â?Ã?® ZOOM software. The results showed that LHRH-modified nanoparticles had a significantly higher uptake (P=0.0001) and better cytotoxicity (P<0.0001) compared to the unmodified nanoparticles. Our preliminary investigations suggest that this new formulation is a promising drug delivery system for targeted therapy of colon cancer.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Trials.
Short communication · 31 Jul 2026
Understanding Bioavailability as a Key Element in Effective Therapeutic Delivery
Research article · 14 Jun 2026
Ensuring Rights and Dignity in Ethical Practices of Clinical Studies with Vulnerable Group and Safeguarding Vulnerable Group Act (2006)
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ghada Mohamed Rady Aboueid”
- BylineArticles whose byline prints “Pegah Varamini”
